Yuta Ito1,2*, Amira Marouf3*, Yasunori Kogure, MD, PhD1*, Junji Koya, MD, PhD1*, Mariko Tabata, MD1,4*, Yuki Saito, MD, PhD1,5*, Sumito Shingaki, MD, PhD1*, Mitsuhiro Yuasa, MD1,6*, Kentaro Yamaguchi, MD1,7*, Julie Bruneau, MD, PhD3,8*, Manon Vavasseur3*, Michaël Dussiot, PhD3*, Isabelle Andre, PhD9*, Akshay Joshi9*, Chantal Lagresle-Peyrou9*, Aude Magerus10*, Sammara Chaubard11*, David Lavergne, PhD11*, Emmanuel Bachy, MD, PhD12*, Erika Brunet, PhD13*, Virginie Fataccioli, PhD14*, Chantal Brouzes, MD15,16*, Camille Laurent, MD, PhD17*, Laurence De Leval, MD18, Alexandra Traverse-Glehen19*, Céline Bossard20*, Marie Parrens, MD, PhD21*, Véronique Meignin22*, Laure Philippe, MD23*, Julien Rossignol3,24*, Felipe Suarez, MD, PhD3,24, Jean-Marie Michot, MD25*, Olivier Tournilhac, MD, PhD26*, Christine Bole-Feysot, PhD27*, Patrick Nitschke28*, Bruno Tesson29*, Cécile Laurent29*, Thierry Jo Molina, MD, PhD3,8*, Vahid Asnafi, MD, PhD15,16*, Sachiko Tsukita30*, Koji Izutsu31,32*, Hiroaki Miyoshi, MD, PhD33*, Seiji Sakata34,35,36*, Akito Dobashi34,35,36*, Kengo Takeuchi34,35,36*, Koichi Ohshima, MD, PhD33*, Philippe Gaulard, MD, PhD14*, Arnaud Jaccard11*, Seishi Ogawa, MD, PhD37,38, Olivier Hermine, MD, PhD3,24, Keisuke Kataoka, MD, PhD1,7 and Lucile Couronne3,15*
1Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan
2Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
3Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications, INSERM U1163, Imagine Institute, Paris City University, Paris, France
4Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
5Department of Gastroenterology, Keio University School of Medicine, Tokyo, Japan
6Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
7Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
8Pathology Department, Necker Children's Hospital, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
9Laboratory of Human Lympho Hematopoiesis, INSERM UMR 1163, Clinical Investigation Center (CIC) 1416-Institut Imagine, Paris City University, Paris, France
10Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris City University, Paris, France
11Hematology department, Limoges University Hospital, Limoges, France
12Hematology Department, Hospices Civils de Lyon; Lymphoma Immuno-Biology (LIB) Team, Université Claude Bernard Lyon 1, Lyon, France
13Laboratory of the « Genome Dynamics in the Immune System », Équipe Labellisée La Ligue Contre Le Cancer, Paris City University, Université Paris Saclay, INSERM UMR 1163, Institut Imagine, Paris, Falkland Islands (The) [Malvinas]
14Pathology Department, Henri Mondor University Hospital, Assistance Publique des Hôpitaux de Paris, INSERM U955, Mondor Institute for Biomedical Research, Paris-Est Créteil University, Créteil, France
15Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France
16INSERM U1151, Institut Necker Enfants Malades (INEM), Paris, France
17Department of Pathology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France; Cancer Research Center of Toulouse, INSERM UMR 1037, ERL5294 CNRS, Université Toulouse III-Paul-Sabatier, Toulouse, France
18Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland
19Department of Pathology, Centre Hospitalier Lyon Sud and Université Claude Bernard Lyon-1, Pierre- Bénite, France
20Department of Pathology, CHU Nantes, Nantes, France; Université de Nantes, INSERM CRCINA, Nantes, France
21Department of Pathology, Bordeaux University Hospital, Bordeaux, France
22Pathology Department, Hôpital Saint Louis, Paris City University, Paris, France
23Department of Hematology, CH Annecy Genevois, Metz-Tessy, France
24Hematology Department, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France
25Gustave Roussy, Département des Innovations Thérapeutiques et Essais Précoces, Université Paris-Saclay, Villejuif, France
26Department of Hematology, University Hospital of Clermont-Ferrand, Clermont Auvergne University, Clermont-Ferrand, France
27Genomics Core Facility, Institut Imagine-Structure Fédérative de Recherche Necker, INSERM U1163 et INSERM US24/CNRS UAR3633, Paris City University, Paris, France
28INSERM Unité Mixte de Recherche 1163, Bioinformatics Platform, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France
29Bioinformatics department, CALYM / LYSARC, Paris, France
30Advanced Comprehensive Research Organization (ACRO), Teikyo University, Toko, Japan
31National Cancer Center Hospital, Tokyo, Japan
32Department of Hematology, Toranomon Hospital, Tokyo, Japan
33Department of Pathology, Kurume University School of Medicine, Kurume, Japan
34Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan
35Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
36Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan
37Center for Hematology and Regenerative Medicine, Department of Medicine (MedH), Karolinska Institutet, Huddinge, Sweden
38Department of Pathology and Tumor Biology, Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan